Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR)
Digestive and Liver Disease · 2024-09 · 56 (9) · 1452-1460
DOI: 10.1016/j.dld.2024.04.027 ↗Kurz gefasst
Leitlinie in der Zeitschrift Digestive and Liver Disease, 2024-09. Verfasst von Vincent Hautefeuille und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Digestive Oncology, Amiens University Hospital - Amiens, France. Electronic address: hautefeuille.vincent@chu-amie…. Hauptthemen laut MEDLINE: Ampulla of Vater, Common Bile Duct Neoplasms, Adenoma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Management of ampullary tumors (AT) is challenging because of a low level of scientific evidence. This document is a summary of the French intergroup guidelines regarding the management of AT, either adenoma (AA) or carcinoma (AC), published in July 2023, available on the website of the French Society of Gastroenterology (SNFGE) (www.tncd.org). METHODS: A collaborative work was conducted under the auspices of French medical, endoscopic, oncological and surgical societies involved in the management of AT. Recommendations are based on recent literature review and expert opinions and graded in three categories (A, B, C), according to quality of evidence. RESULTS: Accurate diagnosis of AT requires at least duodenoscopy and EUS. All patients should be discussed in multidisciplinary tumor board before treatment. Surveillance may only be proposed for small AA in familial adenomatous polyposis. For AA, endoscopic papillectomy is the preferred option only if R0 resection can be achieved. When not possible, surgical papillectomy should be considered. For AC beyond pT1a N0, pancreaticoduodenectomy is the procedure of choice. Adjuvant monochemotherapy (gemcitabine, 5FU) may be proposed. For aggressive tumors (pT3/T4, pN+, R1, poorly differentiated AC, pancreatobiliary differentiation) with high risk of recurrence, 6 months polychemotherapy (CAPOX/FOLFOX for the intestinal subtype and mFOLFIRINOX for the pancreatobiliary or the mixed subtype) may be a valid alternative. Clinical and radiological follow up is recommended for 5 years. CONCLUSIONS: These guidelines help to homogenize and highlight unmet needs in the management of AA and AC. Each individual case should be discussed by a multidisciplinary team.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Digestive Oncology, Amiens University Hospital - Amiens, France. Electronic address: hautefeuille.vincent@chu-amiens.fr.
- Department of Hepato-gastroenterology and Gastrointestinal Oncology, University Institute of Cancerology and Hematology of Saint-Etienne (ICHUSE).
- Department of Oncology, Lille University Hospital; CNRS UMR9020, INSERM UMR1277, University of Lille, Institut Pasteur, Lille, France.
- Department of Digestive Endoscopy, Jean Mermoz Hospital, Ramsay Sante, Lyon, France.
- Department of Surgical Oncology, Centre Léon Bérard -Lyon, France.
- Department of Radiation Oncology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.
Zitieren
APA
Hautefeuille, V., Williet, N., Turpin, A., Napoleon, B., Dupré, A., Huguet, F., Bignon, A. L., Camus, M., Chevaux, J. B., Coriat, R., Cros, J., Edeline, J., Koch, S., Neuzillet, C., Perkins, G., Regimbeau, J. M., Sefrioui, D., Vitellius, C., Vullierme, M. P., …, & Société Française de Radiologie (SFR) (2024). Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease, 56(9), 1452-1460. https://doi.org/10.1016/j.dld.2024.04.027
Vancouver
Hautefeuille V, Williet N, Turpin A, Napoleon B, Dupré A, Huguet F, et al. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease. 2024;56(9):1452-1460. doi:10.1016/j.dld.2024.04.027
BibTeX
@article{Hautefeuille2024,
author = {Hautefeuille, Vincent and Williet, Nicolas and Turpin, Anthony and Napoleon, Bertrand and Dupré, Aurélien and Huguet, Florence and Bignon, Anne Laure and Camus, Marine and Chevaux, Jean-Baptiste and Coriat, Romain and Cros, Jérôme and Edeline, Julien and Koch, Stéphane and Neuzillet, Cindy and Perkins, Géraldine and Regimbeau, Jean Marc and Sefrioui, David and Vitellius, Carole and Vullierme, Marie-Pierre and Bouché, Olivier and Gaujoux, Sébastien and Thésaurus National de Cancérologie Digestive (TNCD), Thésaurus National de Cancérologie Digestive (TNCD) and Société Nationale Française de Gastroentérologie (SNFGE), Société Nationale Française de Gastroentérologie (SNFGE) and Fédération Francophone de Cancérologie Digestive (FFCD), Fédération Francophone de Cancérologie Digestive (FFCD) and Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER), Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) and Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR), Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR) and Société Française de Chirurgie Digestive (SFCD), Société Française de Chirurgie Digestive (SFCD) and Société Française d'Endoscopie Digestive (SFED), Société Française d'Endoscopie Digestive (SFED) and Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT), Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT) and Société́ Française de Pathologie (SFP), Société́ Française de Pathologie (SFP) and Société Française de Radiothérapie Oncologique (SFRO), Société Française de Radiothérapie Oncologique (SFRO) and Réseau National de Référence des Tumeurs Rares du Péritoine (RENAPE), Réseau National de Référence des Tumeurs Rares du Péritoine (RENAPE) and Société Nationale Française de Colo-Proctologie (SNFCP), Société Nationale Française de Colo-Proctologie (SNFCP) and Association Française pour l’Étude du Foie (AFEF), Association Française pour l’Étude du Foie (AFEF) and Société Française de Radiologie (SFR), Société Française de Radiologie (SFR)},
title = {Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR)},
journal = {Digestive and Liver Disease},
year = {2024},
volume = {56},
number = {9},
pages = {1452--1460},
doi = {10.1016/j.dld.2024.04.027}
}
EUVIMED